コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 aC mice degenerate over time, giving rise to progressive hearing loss.
2 revealing new molecular pathways involved in progressive hearing loss.
3 o thrive, thrombocytopenia, photophobia, and progressive hearing loss.
4 and sensitivity and give rise to late-onset progressive hearing loss.
5 natal Tmc1(Bth/+) mice substantially reduced progressive hearing loss.
6 ototoxic drugs or aging diseases, leading to progressive hearing loss.
7 embrane organelle connectomics may result in progressive hearing loss.
8 t degenerated as hearing matured, leading to progressive hearing loss.
9 four mouse strains with different levels of progressive hearing loss.
10 esponse, two had stable hearing, and one had progressive hearing loss.
11 about the genetic basis for its early onset, progressive hearing loss.
12 n an Iranian pedigree that is afflicted with progressive hearing loss.
13 causes outer hair cell defects, and leads to progressive hearing loss.
14 up of patients with pretreatment intractable progressive hearing loss.
15 e mutations in DSPP are also associated with progressive hearing loss.
16 dent elevated thresholds characteristic of a progressive hearing loss.
17 asement membrane and usually associated with progressive hearing loss.
18 ve degeneration, which results in congenital progressive hearing loss.
19 ring in Beethoven mice, a model of dominant, progressive hearing loss.
20 of Caprin1 in mice leads to an early onset, progressive hearing loss.
21 wer regions of stereocilia, and they develop progressive hearing loss.
22 Notably, Yars(DeltaNLS) mice also develop progressive hearing loss.
23 o disrupted retinal vascular development and progressive hearing loss accompanied by sensory hair cel
24 nately found in outer hair cells, leads to a progressive hearing loss after 1 month, suggesting that
27 ntion, but also in predicting late-onset and progressive hearing loss and identifying individuals who
28 ncating mutations causing autosomal dominant progressive hearing loss and missense variants causing a
30 s mellitus and optic atrophy and may include progressive hearing loss and other neurological symptoms
31 use low-frequency nonsyndromic hearing loss, progressive hearing loss, and isolated optic atrophy ass
33 zygous Gfi1(Cre) mice exhibit an early onset progressive hearing loss as compared with their wild-typ
37 The KO-TgAC1 mice displayed delayed onset progressive hearing loss associated with deterioration o
39 noelectrical transducer current, and develop progressive hearing loss, becoming deaf by 8 months of a
41 mmonly used in hearing research: early-onset progressive hearing loss (C57BL/6J and C57BL/6NTac) and
44 man K(+) channel hKv7.4 lead to post-lingual progressive hearing loss (DFNA2), which affects world-wi
46 missense allele linked to autosomal dominant progressive hearing loss (DFNA22), provide an allelic sp
47 profound congenital deafness (DFNB7/B11) and progressive hearing loss (DFNA36), respectively, caused
50 er, they suffer increased mortality and show progressive hearing loss during adulthood despite compen
53 es of mutant genes responsible for inherited progressive hearing loss have suggested possible mechani
54 fully penetrant, nonsyndromic sensorineural progressive hearing loss in a large Costa Rican kindred
55 NA20, a gene causing dominant, nonsyndromic, progressive hearing loss in a three-generation Midwester
56 Using a mutant mouse model (Beethoven) for progressive hearing loss in humans (DFNA36), which harbo
58 a missense change in LOXHD1, a gene causing progressive hearing loss in humans, as the sole variant
61 age of 30 years (range, 14 to 79 years) and progressive hearing loss in the target ear (median basel
62 cipants with NF2 (median age, 23 years) with progressive hearing loss in the target ear (median basel
63 e in DFNA2, an autosomal dominant version of progressive hearing loss, involves degeneration of hair
65 In an extended Israeli family, nonsyndromic progressive hearing loss is caused by three different re
68 a, which has been implicated in nonsyndromic progressive hearing loss, is localized at stereocilia ti
70 "F-actin") assembly, which is disrupted by a progressive hearing loss mutation (p.D1647G, "jordan").
72 , which has been identified in a pre-lingual progressive hearing loss patient in Taiwan, yielded cell
73 se that these events conspire to produce the progressive hearing loss phenotype in Tg-mtTFB1 mice.
74 career as a composer and pianist, including progressive hearing loss, recurring gastrointestinal com
75 non-syndromic, sensorineural, bilateral and progressive hearing loss, segregating as an autosomal do
76 A306T) homozygous mice display delayed onset progressive hearing loss similar to human DFNB8 patients
77 es in gata3(fl/fl) otof-cre(+/-) mice reveal progressive hearing loss that becomes profound by 6-7 mo
78 ps8L2 null-mutant mice exhibit a late-onset, progressive hearing loss that is directly linked to a gr
79 haracterized typically by bilateral, rapidly progressive hearing loss that responds therapeutically t
80 ltransferase TFB1M (Tg-mtTFB1 mice) exhibits progressive hearing loss that we proposed models aspects
81 nse mutation (G321S) that has been linked to progressive hearing loss to further examine the inhibito
82 af, stdf ) leading to recessive, early-onset progressive hearing loss was detected and exome sequenci
83 ent Clrn2(-/-) mice, used here as a model of progressive hearing loss, we report synaptic auditory ab
84 7a(WT/Sh1) mouse model of autosomal dominant progressive hearing loss, which may model MYO7A-associat